Feline Parvovirus (Panleukopenia): Welfare and Prevention

Key Facts

• FPV is one of the most resistant viruses in the environment, surviving for years on contaminated surfaces
• The virus attacks rapidly dividing cells — intestinal crypts, bone marrow, and the developing cerebellum in utero
• Clinical signs include severe vomiting, diarrhea, profound lethargy, and collapse
• Vaccination is highly effective and provides long-lasting immunity
• Outbreaks in unvaccinated shelter populations can kill entire cohorts within days

Welfare Considerations

Feline panleukopenia causes intense suffering — the combination of severe gastroenteritis, vomiting, diarrhea, and immune suppression creates a state of profound systemic illness. Kittens in the acute phase are critically ill, and without intensive supportive care the majority die. The welfare impact on neonates infected in utero — cerebellar hypoplasia causing permanent neurological signs in survivors — extends the welfare consequence beyond the acute disease. Vaccination is the most cost-effective welfare intervention in cat medicine. Community cat programs and shelter vaccination campaigns protect the most vulnerable populations.

What You Can Do

• Vaccinate all cats against panleukopenia starting at 8-9 weeks, boosting at 12 and 16 weeks
• Maintain booster vaccinations throughout life — FPV core vaccination provides critical protection
• Thoroughly disinfect any area where an FPV-positive cat has been using parvocide disinfectants
• Support TNR (trap-neuter-return) programs that include vaccination to protect community cat colonies
• Never skip vaccination in cats that go outdoors or are in contact with other cats